LENZ Therapeutics, Inc./$LENZ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LENZ Therapeutics, Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Ticker
$LENZ
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
-
ISIN
US52635N1037
Website
LENZ Metrics
BasicAdvanced
$831M
-
-$1.77
-
-
Price and volume
Market cap
$831M
52-week high
$30.48
52-week low
$16.54
Average daily volume
216K
Financial strength
Current ratio
23.09
Quick ratio
22.637
Long term debt to equity
0.351
Total debt to equity
0.616
Management effectiveness
Return on assets (TTM)
-17.75%
Return on equity (TTM)
-24.47%
Valuation
Price to book
4.23
Price to tangible book (TTM)
4.23
Price to free cash flow (TTM)
-15.299
Growth
Earnings per share change (TTM)
-93.66%
LENZ News
AllArticlesVideos
LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript
Seeking Alpha·3 weeks ago
LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia
GlobeNewsWire·3 weeks ago
LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LENZ Therapeutics, Inc. stock?
LENZ Therapeutics, Inc. (LENZ) has a market cap of $831M as of May 31, 2025.
What is the P/E ratio for LENZ Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for LENZ Therapeutics, Inc. (LENZ) stock is 0 as of May 31, 2025.
Does LENZ Therapeutics, Inc. stock pay dividends?
No, LENZ Therapeutics, Inc. (LENZ) stock does not pay dividends to its shareholders as of May 31, 2025.
When is the next LENZ Therapeutics, Inc. dividend payment date?
LENZ Therapeutics, Inc. (LENZ) stock does not pay dividends to its shareholders.
What is the beta indicator for LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. (LENZ) does not currently have a Beta indicator.